- Award
- Translated with AI
Vetter may once again call itself a Best Managed Company
Award jury recognizes strategic and sustainable corporate management
– Strategic focus and long-term oriented actions convince once again
– Combining economic success and sustainability
– Family business in the spotlight for the 2025 award
Vetter, a partner to global pharmaceutical companies for the production of some life-saving medications, was once again awarded as a Best Managed Company in its anniversary year – and this is already the sixth consecutive time. For 75 years, the family business has stood for quality, responsibility, and great commitment to improving the quality of life for patients worldwide. The award once again demonstrates how the company pursues its strategic goals with focus and acts accordingly. The award jury also sees long-term thinking as an important success factor, exemplified by Vetter. The Best Managed Companies Award is organized by Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federation of German Industries (BDI). During a ceremonial award ceremony on May 22 at the Palmengarten Society House in Frankfurt, the trophy and certificate were presented to the pharmaceutical service provider.
Vetter Managing Director Titus Ottinger emphasizes: “Participating in the Best Managed Companies Award willingly subjects us to a critical external review in a stringent, demanding selection process. This is very important feedback for us from experienced experts across various fields. This year, we were able to demonstrate even more explicitly how deeply we have embedded the values of our family business into our structures. This makes the award even more valuable to us.”
This is how Vetter convinced
To be awarded the Best Managed Companies, a company must convince a highly qualified jury in four key business areas, known as value drivers: strategy, productivity and innovation, culture and commitment, as well as governance and finance. After a personal coaching session, participating companies answer a comprehensive and detailed questionnaire. In 2025, the jury also evaluated criteria that are specifically aligned with the values and unique profile of family businesses. Vetter was able to impress in all four areas through the consistency and prudence with which the pharmaceutical service provider advances and develops its projects and processes in accordance with its corporate values.
Innovation power and sense of responsibility as a foundation
With a revenue growth of eleven percent to 1.1 billion euros last year, Vetter demonstrates how consistent focus on all four relevant value drivers bears fruit. The positive results for 2024 are also reflected in other areas: the pharmaceutical service provider was able to continue its steady growth among employees. Currently, the globally active family business from Ravensburg offers over 7,000 people an attractive and responsible workplace. With investments of 269 million euros in expanding and modernizing its sites in Germany, Austria, and the USA, Vetter continues to invest in the foundation for dynamic organic growth in the production of complex injectable medications. In a politically and economically challenging environment, the company proves to be a secure employer and a reliable partner for pharmaceutical and biotech companies worldwide.
Strategic priorities for the company's development in 2024 also focused on maintaining high and reliable quality of services offered, sustainable growth, and driving digital transformation and innovations across all areas of the company. Numerous projects related to digitizing production processes as well as in AI, human-machine interaction, cloud & cybersecurity are currently ongoing or have already been completed. With a comprehensive innovation management process characterized by interactive formats such as Innovation World Café, Innovation Bootcamp, Science Slam, and Hackathon, the employees of the pharmaceutical service provider ensure that trends and technologies are recognized early and targeted for innovation. For many years, Vetter has also placed a strategic focus on sustainability in the areas of ecology, economy, and social responsibility. The family business has now published its fourth comprehensive sustainability report.
Markus Seiz, Program Director of Best Managed Companies and Director at Deloitte Private, states: “Vetter exemplifies how factors that cannot be measured by simple metrics are central to the economic success of a globally active family business. In our view, the way in which strategic vision and responsible management are combined makes Vetter a pioneer of sustainable and innovation-driven corporate leadership.”
Vetter Pharma International GmbH
88212 Ravensburg
Germany








